Vertical Soft Tissue Augmentation With CTG vs ADM
Harvard Medical School (HMS and HSDM) · NCT05729607
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–99 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 28
- US sites recruiting
- 1
- Study start
- May 26, 2023
- Record last updated
- September 18, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The study aims at comparing two different approaches for vertical soft tissue augmentation at implant sites exhibiting soft tissue dehiscences: autogenous connective tissue graft vs acellular dermal matrix + enamel matrix derivative
Being studied: Vertical soft tissue augmentation; Vertical soft tissue augmentation
Conditions: Implant Complication
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion criteria
- Age ≥ 18 years
- Periodontally and systemically healthy
- Full-mouth plaque score and full-mouth bleeding score ≤ 20% (measured at four sites per tooth)
- Presence of single functional dental implant in the anterior with a PSTD
- Implants diagnosed as healthy (Berglundh et al., 2018)
Exclusion criteria are
- Contraindications for surgery
- Systemic condition (e.g. diabetes mellitus, HIV, cancer, etc) that could compromise wound healing
- Patients pregnant or attempting to get pregnant (self-reported)
- Untreated periodontitis
- Untreated peri-implant mucositis or peri-implantitis (Berglundh et al., 2018)
- Smoking, defined as self-reported daily habit. Occasional smokers won't be excluded
- History of soft tissue grafting at the implant site within the last 6 months
Recruiting US locations
Harvard School of Dental Medicine
Boston, MA 02115
Site contact: Lorenzo Tavelli, DDS, MS · 7346044364 · lorenzo_tavelli@hsdm.harvard.edu
Study contacts (from the official record)
- Lorenzo Tavelli, DDS, MS · 734-604-4364 · lorenzo_tavelli@hsdm.harvard.edu
Similar studies in Massachusetts
All healthy volunteers studies in Massachusetts →- RecruitingHealthy volunteersPhase 1/Phase 2
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Novartis Pharmaceuticals
- Location
- Boston, MA + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1
Study to Evaluate the Safety, Pharmacokinetic, and Pharmacodynamic Effects of MY006 in Healthy Volunteers and Patients With Peanut Allergy
Mabylon AG
- Location
- Boston, MA + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1
Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HTX-001
Haya Therapeutics, Inc.
- Location
- Boston, MA + 1 other US site
- Eligibility basics
- Ages 18–70
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Boston, MA + 49 other US sites
- Eligibility basics
- Ages 60+